As of 2024-10-03, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (10.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.82 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -669.1%.
The range of the Relative Valuation is (8.90) - (12.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.4x - 28.2x | 18.0x |
| Forward P/E multiples | 17.7x - 25.4x | 23.2x |
| Fair Price | (8.90) - (12.77) | (10.36) |
| Upside | -589.0% - -801.5% | -669.1% |
| Date | P/E |
| 2024-10-03 | -3.91 |
| 2024-10-02 | -3.62 |
| 2024-10-01 | -3.21 |
| 2024-09-30 | -3.29 |
| 2024-09-27 | -3.35 |
| 2024-09-26 | -3.27 |
| 2024-09-25 | -3.21 |
| 2024-09-24 | -3.29 |
| 2024-09-23 | -3.25 |
| 2024-09-20 | -3.35 |
| 2024-09-19 | -3.48 |
| 2024-09-18 | -3.46 |
| 2024-09-17 | -3.54 |
| 2024-09-16 | -3.50 |
| 2024-09-13 | -3.80 |
| 2024-09-12 | -3.48 |
| 2024-09-11 | -3.46 |
| 2024-09-10 | -3.44 |
| 2024-09-09 | -3.38 |
| 2024-09-06 | -3.29 |
| 2024-09-05 | -3.42 |
| 2024-09-04 | -3.62 |
| 2024-09-03 | -3.64 |
| 2024-08-30 | -3.64 |
| 2024-08-29 | -3.48 |
| 2024-08-28 | -3.38 |
| 2024-08-27 | -3.40 |
| 2024-08-26 | -3.50 |
| 2024-08-23 | -3.52 |
| 2024-08-22 | -3.40 |
| 2024-08-21 | -3.50 |
| 2024-08-20 | -3.54 |
| 2024-08-19 | -3.78 |
| 2024-08-16 | -3.90 |
| 2024-08-15 | -3.92 |
| 2024-08-14 | -3.70 |
| 2024-08-13 | -3.58 |
| 2024-08-12 | -3.66 |
| 2024-08-09 | -4.02 |
| 2024-08-08 | -4.04 |
| 2024-08-07 | -3.90 |
| 2024-08-06 | -4.00 |
| 2024-08-05 | -4.20 |
| 2024-08-02 | -4.10 |
| 2024-08-01 | -4.34 |
| 2024-07-31 | -4.60 |
| 2024-07-30 | -4.62 |
| 2024-07-29 | -4.68 |
| 2024-07-26 | -4.84 |
| 2024-07-25 | -4.84 |